Investments
118Portfolio Exits
33Funds
5Service Providers
1About Quaker BioVentures
Quaker BioVentures is a venture capital firm investing in life science companies. The firm leads investments across the spectrum of the life science industry, including biopharmaceuticals, medical devices, human diagnostics, specialty pharmaceuticals, and healthcare services. Quaker BioVentures invests in companies at all stages of development, from early stage start-ups to public companies. Founded in 2003, the firm is currently investing Quaker BioVentures II, a $420 million fund formed in 2007. Quaker BioVentures manages over $700 million in committed capital.
Want to inform investors similar to Quaker BioVentures about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Quaker BioVentures News
Apr 30, 2013
The venture investors in RainDance that participated in the Series E round included Mohr Davidow Ventures, Quaker BioVentures, Alloy Ventures, Acadia Woods Partners, and Sectoral Asset Management. RainDance plans to use the proceeds of this ...See all stories on this topic »
Quaker BioVentures Investments
118 Investments
Quaker BioVentures has made 118 investments. Their latest investment was in Minti as part of their Seed VC on June 6, 2021.
Quaker BioVentures Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
6/1/2021 | Seed VC | Minti | $1M | Yes | 1 | |
5/29/2019 | Series D | Intact Vascular | $25M | No | 2 | |
5/29/2019 | Series B | Vesper Medical | $37M | No | 5 | |
2/15/2019 | Seed VC | |||||
5/21/2018 | Series A - II |
Date | 6/1/2021 | 5/29/2019 | 5/29/2019 | 2/15/2019 | 5/21/2018 |
|---|---|---|---|---|---|
Round | Seed VC | Series D | Series B | Seed VC | Series A - II |
Company | Minti | Intact Vascular | Vesper Medical | ||
Amount | $1M | $25M | $37M | ||
New? | Yes | No | No | ||
Co-Investors | |||||
Sources | 1 | 2 | 5 |
Quaker BioVentures Portfolio Exits
33 Portfolio Exits
Quaker BioVentures has 33 portfolio exits. Their latest portfolio exit was Vesper Medical on December 14, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
12/14/2021 | Acquired | 5 | |||
7/20/2021 | Acquired | 1 | |||
7/16/2021 | IPO | Public | 4 | ||
Date | 12/14/2021 | 7/20/2021 | 7/16/2021 | ||
|---|---|---|---|---|---|
Exit | Acquired | Acquired | IPO | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | ||||
Sources | 5 | 1 | 4 |
Quaker BioVentures Fund History
5 Fund Histories
Quaker BioVentures has 5 funds, including Quaker BioVentures II LP.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
4/28/2008 | Quaker BioVentures II LP | Late-Stage Venture Capital | Closed | $420M | 1 |
12/31/2004 | Quaker BioVentures | ||||
12/31/2004 | Garden State Life Sciences Venture Fund | ||||
9/23/2004 | BioAdvance Ventures LP | ||||
8/26/2004 | Quaker BioVentures Tobacco Fund |
Closing Date | 4/28/2008 | 12/31/2004 | 12/31/2004 | 9/23/2004 | 8/26/2004 |
|---|---|---|---|---|---|
Fund | Quaker BioVentures II LP | Quaker BioVentures | Garden State Life Sciences Venture Fund | BioAdvance Ventures LP | Quaker BioVentures Tobacco Fund |
Fund Type | Late-Stage Venture Capital | ||||
Status | Closed | ||||
Amount | $420M | ||||
Sources | 1 |
Quaker BioVentures Service Providers
1 Service Provider
Quaker BioVentures has 1 service provider relationship
Service Provider | Associated Rounds | Provider Type | Service Type |
|---|---|---|---|
Counsel |
Service Provider | |
|---|---|
Associated Rounds | |
Provider Type | Counsel |
Service Type |
Partnership data by VentureSource
Quaker BioVentures Team
5 Team Members
Quaker BioVentures has 5 team members, including current Chief Financial Officer, Eric Emrich.
Name | Work History | Title | Status |
|---|---|---|---|
Eric Emrich | Chief Financial Officer | Current | |
Name | Eric Emrich | ||||
|---|---|---|---|---|---|
Work History | |||||
Title | Chief Financial Officer | ||||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
